<?xml version="1.0" encoding="UTF-8"?>
<p id="par0125">Nucleoside analogues are a good alternative in some viral infections. These include remdesivir (GS-5734) which has shown therapeutic efficacy in infections caused by the Ebola virus, Nipah and the SARS and MERS coronaviruses.
 <xref rid="bib0345" ref-type="bibr">
  <sup>34</sup>
 </xref> Safety and bioavailability data obtained in Ebola patients could be the basis for its use in humans infected with SARS-CoV-2. Several clinical trials are currently underway in China to establish its efficacy in both non-hospitalised and severely ill hospitalised patients.
 <xref rid="bib0350" ref-type="bibr">
  <sup>35</sup>
 </xref>
</p>
